Urological problems in patients with meningomyelocele: Diagnostic studies and management;Urologische erkrankungen bei patienten mit meningomyelozele: Diagnostik und management

Urologe - Ausgabe A

Volumn 46, Issue 12, 2007, Pages 1620-1642

  Stein, R ^a   Schroder A ^a   Beetz, R ^a   Ermert, A ^b   Filipas, D ^c   Fisch, M ^d   Goepel, M ^e   Korner I ^f   Schonberger B ^g   Sparwasser, C ^h   Stohrer M ⁱ   Thuroff J W ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Ermert   (Germany)

^c Filipas   (Germany)

^d Urologisches Zentrum Hamburg   (Germany)

^e Klinikum Niederberg   (Germany)

^f Krankenhaus Barmherzigen Brüder   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Bundeswehrkrankenhaus Ulm   (Germany)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Antibacterial prophylaxis; Bowel function; Clean intermittent catheterization; Latex allergy; Meningomyelocele; Neurogenic bladder; Pharmacotherapy; Urinary diversion; Urinary tract infection

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BOTULINUM TOXIN A; CEFACLOR; CEFIXIME; CEFPODOXIME PROXETIL; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN; COTRIMAZINE; CYSTONORM; DARIFENACIN; HEXAL; HOLSTEN; LATEX; MAXMEDIC; NITROFURANTOIN; OXYB; OXYBUTON; OXYBUTYNIN; OXYMEDIN; PHENOXYBENZAMINE; PROPIVERINE; RATIOPHARM; RYOL; SOLIFENACIN; SPASMO RHIOVAL; SPASYT; STADA; TAMSULOSIN; TOLTERODINE; TRIMETHOPRIM; TROSPI; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT;

ALLERGY; ANAMNESIS; ANTIBIOTIC THERAPY; CONSERVATIVE TREATMENT; CONTRACTURE; CYSTITIS; DETRUSOR DYSSYNERGIA; DISEASE CLASSIFICATION; FRACTURE; HUMAN; INCIDENCE; INFERTILITY; KYPHOSIS; MALNUTRITION; MENINGOMYELOCELE; OBESITY; PATIENT CARE; PATIENT COMPLIANCE; PYELONEPHRITIS; REVIEW; RISK FACTOR; SCOLIOSIS; SCREENING; SEXUAL DYSFUNCTION; URINARY TRACT INFECTION; URODYNAMICS; UROLOGIC SURGERY; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; BLADDER CATHETERIZATION; CHILD; COOPERATION; INFANT; MASS SCREENING; MULTIMODALITY CANCER THERAPY; NEURAL TUBE DEFECT; NEUROGENIC BLADDER; NEWBORN; OVERACTIVE BLADDER; PHYSIOLOGY; PRESCHOOL CHILD; URINARY DIVERSION; URINARY TRACT DISEASE; VESICOURETERAL REFLUX;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ANTIBIOTIC PROPHYLAXIS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; HUMANS; INFANT; INFANT, NEWBORN; MASS SCREENING; MENINGOMYELOCELE; MUSCARINIC ANTAGONISTS; NEURAL TUBE DEFECTS; PATIENT CARE TEAM; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; URINARY CATHETERIZATION; URINARY DIVERSION; URINARY TRACT INFECTIONS; URODYNAMICS; UROLOGIC DISEASES; VESICO-URETERAL REFLUX;

EID: 36949021035     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1522-3     Document Type: Review

References (160)

1. McGuire EJ, Woodside JR, Borden TA, Weiss RM (1981) Prognostic value urodynamic testing in myelodysplastic patients. J Urol 126: 205-209
2. Bauer SB, Hallett M, Khoshbin S et al. (1984) Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252: 650-652
3. Galloway NT, Mekras JA, Helms M, Webster GD (1991) An objective score to predict upper tract deterioration in myelodysplasia. J Urol 145: 535-537
4. Lais A, Kasabian NG, Dyro FM et al. (1993) The neurosurgical implications of continuous neurourological surveillance of children with myelodysplasia. J Urol 150: 1879-1883
5. Bauer S (2000) Clean intermittent catheterization of infants with myelodysplasia - the argument for early asssessment and treatment of infants with spina bifida. Dialog Ped Urol 23: 2-3
6. Reiner I, Jones M, Donnell S, Rickwood AM (1992) Incidence of normal micturition in myelomeningocele patients. Arch Dis Child 67: 640-641
7. Sillen U, Hansson E, Hermansson G et al. (1996) Development of the urodynamic pattern in infants with myelomeningocele. Br J Urol 78: 596-601
8. Dator DP, Hatchett L, Dyro FM et al. (1992) Urodynamic dysfunction in walking myelodysplastic children. J Urol 148: 362-365
9. Tarcan T, Bauer S, Olmedo E et al. (2001) Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? J Urol 165: 564-567
10. Ghoniem GM, Roach MB, Lewis VH, Harmon EP (1990) The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients. J Urol 144: 1440-1442
11. Beetz R, Bokenkamp A, Brandis M et al. (2001) Diagnosis of congenital dilatation of the urinary tract. Consensus Group of the Pediatric Nephrology Working Society in cooperation with the Pediatric Urology Working Group of the German Society of Urology and with the Pediatric Urology Working Society in the Germany Society of Pediatric Surgery. Urologe A 40: 495-509
12. Dinkel E, Ertel M, Dittrich M et al. (1985) Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 15: 38-43
13. Lebowitz RL, Olbing H, Parkkulainen KV et al. (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 15: 105-109
14. Höfner K (2004) Messung des Leak Point Pressure. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 105-110
15. Madersbacher H, Stöhrer M, Schönberger B (2004) Urodynamik bei neurogener Blasenfunktionsstörung. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 217-236
16. Decter RM, Harpster L (1992) Pitfalls in determination of leak point pressure. J Urol 148: 588-591
17. Thon WF, Denil J, Stief CG, Jonas U (1994) Urologische Langzeitbetreuung von Patienten mit Meningomyelozele. Akt Urol 25: 55-76
18. Schultz-Lampel D, Schönberger B (2004) Urodynamik bei Blasenfunktionsstörungen des Kindes. In: Palmtag H, Goebel M, Heidler H (eds) Urodynamik. Springer, Berlin Heidelberg New York, pp 189-206
19. Landau EH, Churchill BM, Jayanthi VR et al. (1994) The sensitivity of pressure specific bladder volume versus total bladder capacity as a measure of bladder storage dysfunction. J Urol 152: 1578-1581
20. Norgaard JP, Gool JD van, Hjalmas K et al. (1998) Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. Br J Urol 81(Suppl 3): 1-16
21. Neveus T, Gontard A von, Hoebeke P et al. (2006) The standardization of terminology of lower urinary tract function in children and adolescents: Report from the Standardisation Committee of the International Children's Continence Society. J Urol 176: 314-324
22. Yeung CK (1998) Continuous real-time ambulatory urodynamic monitoring in infants and young children using infrared telemetry. Br J Urol 81(Suppl 3): 76-80
23. Gordon I, Piepsz A, Colarinha P et al. (2000) Empfehlungen zur Durchführung der Nierenfunktionsszintigraphie mit und ohne Furosemidbelastung. Leitlinie übernommen vom Pediatric Committee der European Association of Nuclear Medicine (EANM) (2000). Nuklearmediziner 4: 297-309
24. Schwartz G, Brion L, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34: 571-590
25. Adolescents NHBPEPWGoHCiCa (1996) Update on the 1987 Task Force Report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98: 649-658
26. Goessl C, Knispel HH, Fiedler U et al. (1998) Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology 51: 94-98
27. Haferkamp A, Staehler G, Gerner HJ, Dorsam J (2000) Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 38: 250-254
28. Ferrara P, D'Aleo CM, Tarquini E et al. (2001) Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int 87: 674-678
29. Connor JP, Betrus G, Fleming P et al. (1994) Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 151: 1045-1047
30. Kaplinsky R, Greenfield S, Wan J, Fera M (1996) Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder. J Urol 156: 753-756
31. Oka T, Nakano K, Kirimoto T, Matsuura N (2001) Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats. Jpn J Pharmacol 87: 27-33
32. Todorova A, Vonderheid-Guth B, Dimpfel W (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41: 636-644
33. Perrigot M, Delauche-Cavallier MC, Amarenco G et al. (1996) Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunction. DORALI Study Group. Neurourol Urodyn 15: 119-131
34. Austin PF, Homsy YL, Masel JL et al. (1999) alpha-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol 162: 1064-1067
35. Donohoe JM, Combs AJ, Glassberg KI (2005) Primary bladder neck dysfunction in children and adolescents II: Results of treatment with alpha-adrenergic antagonists. J Urol 173: 212-216
36. Park JM, McGuire EJ, Koo HP et al. (2001) External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience. J Urol 165: 2383-2388
37. Bloom DA, Knechtel JM, McGuire EJ (1990) Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures. J Urol 144: 430-444
38. Shochat SJ, Perlmutter AD (1972) Myelodysplasia with severe neonatal hydronephrosis: The value of urethral dilatation. J Urol 107: 146-148
39. Schulte-Baukloh H, Michael T, Schobert J et al. (2002) Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59: 325-328
40. Riccabona M, Koen M, Schindler M et al. (2004) Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171: 845-848
41. Marte A, Vessella A, Cautiero P et al. (2005) Efficacy of toxin-A Botulinum for treating intractable bladder hypractivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocistoplasty. Minerva Pediatr 57: 35-40
42. Stöhrer M, Sauerwein D (2001) Der intermittierende Katheterismus bei neurogener Blasenfunktionsstörung. Urologe B 41: 354-368
43. Kopp C, Greenfield SP (1993) Effects of neurogenic bladder dysfunction in utero seen in neonates with myelodysplasia. Br J Urol 71: 739-742
44. Gool JD van, Dik P, Jong TP de (2001) Bladder-sphincter dysfunction in myelomeningocele. Eur J Pediatr 160: 414-420
45. Baskin LS, Kogan BA, Benard F (1990) Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 66: 532-534
46. Kaefer M, Pabby A, Kelly M et al. (1999) Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele. J Urol 162: 1068-1071
47. Wu HY, Baskin LS, Kogan BA (1997) Neurogenic bladder dysfunction due to myelomeningocele: Neonatal versus childhood treatment. J Urol 157: 2295-2297
48. Edelstein RA, Bauer SB, Kelly MD et al. (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154: 1500-1504
49. McDonald CM, Scavone T (2000) Clean intermittent catheterization of infants with myelodysplasia, initiation of clean intermittent catheterization in infants with myelodysplasia. Dialog Ped Urol 23: 4-6
50. Teichman JM, Scherz HC, Kim KD et al. (1994) An alternative approach to myelodysplasia management: Aggressive observation and prompt intervention. J Urol 152: 807-811
51. Kasabian NG, Bauer SB, Dyro FM et al. (1992) The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146: 840-843
52. Kaufman AM, Ritchey ML, Roberts AC et al. (1996) Decreased bladder compliance in patients with myelomeningocele treated with radiological observation. J Urol 156: 2031-2033
53. Sidi AA, Dykstra DD, Gonzalez R (1986) The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study. J Urol 135: 90-93
54. Schlager TA, Clark M, Anderson S (2001) Effect of a single-use sterile catheter for each void on the frequency of bacteriuria in children with neurogenic bladder on intermittent catheterization for bladder emptying. Pediatrics 108: 71
55. Hudson E, Murahata RI (2005) The 'no-touch' method of intermittent urinary catheter insertion: Can it reduce the risk of bacteria entering the bladder? Spinal Cord 43: 611-614
56. McLaughlin JF, Murray M, Van Zandt K, Carr M (1996) Clean intermittent catheterization. Dev Med Child Neurol 38: 446-454
57. Borzyskowski M, Cox A, Edwards M, Owen A (2004) Neuropathic bladder and intermittent catheterization: Social and psychological impact on families. Dev Med Child Neurol 46: 160-167
58. Edwards M, Borzyskowski M, Cox A, Badcock J (2004) Neuropathic bladder and intermittent catheterization: Social and psychological impact on children and adolescents. Dev Med Child Neurol 46: 168-177
59. Lindehall B, Abrahamsson K, Hjalmas K et al. (2004) Complications of clean intermittent catheterization in boys and young males with neurogenic bladder dysfunction. J Urol 172: 1686-1688
60. Campbell JB, Moore KN, Voaklander DC, Mix LW (2004) Complications associated with clean intermittent catheterization in children with spina bifida. J Urol 171: 2420-2422
61. Wyndaele JJ, Maes D (1990) Clean intermittent self-catheterization: a 12-year followup. J Urol 143: 906-908
62. Thirumavalavan VS, Ransley PG (1992) Epididymitis in children and adolescents on clean intermittent catheterisation. Eur Urol 22: 53-56
63. Kaye MC, Levin HS, Montague DK, Pontes JE (1992) Squamous cell carcinoma of the bladder in a patient on intermittent self-catheterization. Cleve Clin J Med 59: 645-646
64. Reisman EM, Preminger GM (1989) Bladder perforation secondary to clean intermittent catheterization. J Urol 142: 1316-1317
65. Solomon MH, Koff SA, Diokno AC (1980) Bladder calculi complicating intermittent catheterization. J Urol 124: 140-141
66. Schlager TA, Dilks S, Trudell J et al. (1995) Bacteriuria in children with neurogenic bladder treated with intermittent catheterization: natural history. J Pediatr 126: 490-496
67. Ottolini MC, Shaer CM, Rushton HG et al. (1995) Relationship of asymptomatic bacteriuria and renal scarring in children with neuropathic bladders who are practicing clean intermittent catheterization. J Pediatr 127: 368-372
68. Gonzalez R, Schimke CM (2002) Strategies in urological reconstruction in myelomeningocele. Curr Opin Urol 12: 485-490
69. Adams MC, Joseph DB (2002) Urinary tract reconstruction in children. In: Walsh PC, Retik A, Vaughan ED Jr, Wein AJ (eds) Campbell's Urology, 8th edn. Saunders, Philadelphia, pp 2508-2563
70. Rawashdeh YF, Jorgensen TM, Olsen LH, Djurhuus JC (2004) The outcome of detrusor myotomy in children with neurogenic bladder dysfunction. J Urol 171: 2654-2656
71. MacNeily AE, Afshar K, Coleman GU, Johnson HW (2003) Autoaugmentation by detrusor myotomy: Its lack of effectiveness in the management of congenital neuropathic bladder. J Urol 170: 1643-1646
72. Etker S (1996) Eckstein's Ureterocystoplasty: Notes. In: Williams DI, Etker S (eds) Contemporary issues in pediatric urology in memoriam Herbert B Eckstein. Pediatric Cerrahi Dergisi, Istanbul, pp 213-215
73. Bellinger MF (1993) Ureterocystoplasty: A unique method for vesical augmentation in children. J Urol 149: 811-813
74. Stein R, Beetz R, Thuroff JW (2004) Children and youths with neurogenic disturbances of bladder function. Bladder augmentation, substitution and the diversion of urine. Urologe A 43: 414-420
75. Woodhouse CR (1992) Reconstruction of the lower urinary tract for neurogenic bladder: lessons from the adolescent age group. Br J Urol 69: 589-593
76. Gonzalez R, Sidi AA (1985) Preoperative prediction of continence after enterocystoplasty or undiversion in children with neurogenic bladder. J Urol 134: 705-707
77. Herschorn S, Hewitt RJ (1998) Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 52: 672-678
78. Rink RC, Hollensbe D, Adams MC (1995) Complications of bladder augmentation in children and comparision of gastrointestinal segments. AUA Update series XIV: 122-128
79. Pope JCt, Keating MA, Casale AJ, Rink RC (1998) Augmenting the augmented bladder: Treatment of the contractile bowel segment. J Urol 160: 854-857
80. Bauer SB, Hendren WH, Kozakewich H et al. (1992) Perforation of the augmented bladder. J Urol 148: 699-703
81. Blyth B, Ewalt DH, Duckett JW, Snyder HM 3rd (1992) Lithogenic properties of enterocystoplasty. J Urol 148: 575-579
82. Palmer LS, Franco I, Kogan SJ et al. (1993) Urolithiasis in children following augmentation cystoplasty. J Urol 150: 726-729
83. Kronner KM, Casale AJ, Cain MP et al. (1998) Bladder calculi in the pediatric augmented bladder. J Urol 160: 1096-1103
84. Mitrofanoff P (1980) [Trans-appendicular continent cystostomy in the management of the neurogenic bladder]. Chir Pediatr 21: 297-305
85. Mevorach RA, Hulbert WC, Merguerian PA, Rabinowitz R (1992) Perforation and intravesical erosion of a ventriculoperitoneal shunt in a child with an augmentation cystoplasty. J Urol 147: 433-434
86. Couillard DR, Vapnek JM, Rentzepis MJ, Stone AR (1993) Fatal perforation of augmentation cystoplasty in an adult. Urology 42: 585-588
87. Matthews GJ, Churchill BA, McLorie GA, Khoury AE (1996) Ventriculoperitoneal shunt infection after augmentation cystoplasty. J Urol 155: 686-688
88. Yerkes EB, Rink RC, Cain MP et al. (2001) Shunt infection and malfunction after augmentation cystoplasty. J Urol 165: 2262-2264
89. Husmann OA, Cain MP (2001) Fecal and urinary continence after ileal cecal cystoplasty for the neurogenic bladder. J Urol 165: 922-925
90. Hunt GM, Poulton A (1995) Open spina bifida: A complete cohort reviewed 25 years after closure. Dev Med Child Neurol 37: 19-29
91. Stein R, Fisch M, Stockle M et al. (1996) Colonic conduit in children: Protection of the upper urinary tract 16 years later? J Urol 156: 1146-1150
92. Shapiro SR, Lebowitz R, Coldny AH (1975) Fate of 90 children with ileal conduit urinary diversion a decade later: Analysis of complication, pyelography, renal function and bacteriology. J Urol 114: 289-295
93. Schwarz GR, Jeffs RD (1975) Ileal conduit urinary diversion in children: Computer analysis of followup from 2 to 16 years. J Urol 114: 285
94. Middleton AW, Hendren WH (1976) Ileal conduit in children at the Massachusetts Genaral Hospital from 1955 to 1970. J Urol 115: 591
95. Duckett JW Jr (1974) Cutaneous vesicostomy in childhood. The Blocksom technique. Urol Clin North Am 1: 485-495
96. Borjeson MC, Lagergren J (1990) Life conditions of adolescents with myelomeningocele. Dev Med Child Neurol 32: 698-706
97. Peeker R, Damber JE, Hjalmas K et al. (1997) The urological fate of young adults with myelomeningocele: A three decade follow-up study. Eur Urol 32: 213-217
98. Light JK, Pietro T (1986) Alteration in detrusor behavior and the effect on renal function following insertion of the artificial urinary sphincter. J Urol 136: 632-635
99. Kassouf W, Capolicchio G, Berardinucci G, Corcos J (2001) Collagen injection for treatment of urinary incontinence in children. J Urol 165: 1666-1668
100. Gonzalez R, Sheldon CA (1982) Artificial sphincters in children with neurogenic bladders: long-term results. J Urol 128: 1270-1272
101. Grein U, Schreiter F (1990) Le sphincter artificiel chez l'enfant. J Urol 2: 93
102. Kryger JV, Spencer Barthold J, Fleming P, Gonzalez R (1999) The outcome of artificial urinary sphincter placement after a mean 15-year follow-up in a paediatric population. BJU Int 83: 1026-1031
103. Kryger JV, Gonzalez R, Barthold JS (2000) Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol 163: 256-263
104. Herndon CD, Rink RC, Shaw MB et al. (2004) Experience with non-cycled artificial urinary sphincters. BJU Int 93: 1049-1052
105. Dik P, Van Gool JD, De Jong TP (1999) Urinary continence and erectile function after bladder neck sling suspension in male patients with spinal dysraphism. BJU Int 83: 971-975
106. Kropp KA, Angwafo FF (1986) Urethral lengthening and reimplantation for neurogenic incontinence in children. J Urol 135: 533-536
107. Nill TG, Peller PA, Kropp KA (1990) Management of urinary incontinence by bladder tube urethral lengthening and submucosal reimplantation. J Urol 144: 559-563
108. Kropp KA (1999) Bladder neck reconstruction in children. Urol Clin North Am 26: 661-672
109. Waters PR, Chehade NC, Kropp KA (1997) Urethral lengthening and reimplantation: Incidence and management of catheterization problems. J Urol 158: 1053-1056
110. Snodgrass W (1997) A simplified Kropp procedure for incontinence. J Urol 158: 1049-1052
111. Salle JL, Fraga JC de, Amarante A et al. (1994) Urethral lengthening with anterior bladder wall flap for urinary incontinence: a new approach. J Urol 152: 803-806
112. Salle JL, McLorie GA, Bagli DJ, Khoury AE (1997) Urethral lengthening with anterior bladder wall flap (Pippi Salle procedure): Modifications and extended indications of the technique. J Urol 158: 585-590
113. Mouriquand PD, Sheard R, Phillips N et al. (1995) The Kropp-onlay procedure (Pippi Salle procedure): A simplification of the technique of urethral lengthening. Preliminary results in eight patients. Br J Urol 75: 656-662
114. Rink RC, Adams MC, Keating MA (1994) The flip-flap technique to lengthen the urethra (Salle procedure) for treatment of neurogenic urinary incontinence. J Urol 152: 799-802
115. Cass AS, Luxenberg M, Johnson CF, Gleich P (1985) Incidence of urinary tract complications with myelomeningocele. Urology 25: 374-378
116. Klose AG, Sackett CK, Mesrobian HG (1990) Management of children with myelodysplasia: urological alternatives. J Urol 144: 1446-1449
117. Flood HD, Ritchey ML, Bloom DA et al. (1994) Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 152: 1574-1577
118. Lindehall B, Claesson I, Hjalmas K, Jodal U (1991) Effect of clean intermittent catheterisation on radiological appearance of the upper urinary tract in children with myelomeningocele. Br J Urol 67: 415-419
119. Hefti F (Hrsg) (1997) Kinderorthopädie in der Praxis. Springer, Berlin Heidelberg New York
120. Samuelsson L, Skoog M (1988) Ambulation in patients with myelomeningocele: A multivariate statistical analysis. J Pediatr Orthop 8: 569-575
121. Greene WB (1998) Treatment of hip and knee problems in myelomeningocele. J Bone Joint Surg Am 80: 1068-1082
122. Eseverri JL, Botey J, Cozzo M et al. (1999) Prevalence of allergy to latex in the pediatric population. Allergol Immunopathol (Madr) 27: 133-140
123. Rendeli C, Nucera E, Ausili E et al. (2005) Latex sensitisation and allergy in children with myelomeningocele. Childs Nerv Syst 22: 28-32
124. Palmieri A, Battistini E, Cama A et al. (1998) High prevalence of sensitization to inhalant allergens in patients with myelomeningocele allergic to latex products. Eur J Pediatr Surg 8(Suppl 1): 67-68
125. Shah S, Cawley M, Gleeson R et al. (1998) Latex allergy and latex sensitization in children and adolescents with meningomyelocele. J Allergy Clin Immunol 101: 741-746
126. Pittman T, Kiburz J, Gabriel K et al. (1995) Latex allergy in children with spina bifida. Pediatr Neurosurg 22: 96-100
127. Yassin MS, Sanyurah S, Lierl MB et al. (1992) Evaluation of latex allergy in patients with meningomyelocele. Ann Allergy 69: 207-211
128. Kurup VP, Kelly KJ, Resnick A et al. (1992) Characterization of latex antigen and demonstration of latex-specific antibodies by enzyme-linked immunosorbent assay in patients with latex hypersensitivity. Allergy Proc 13: 329-334
129. Nguyen DH, Burns MW, Shapiro GG et al. (1991) Intraoperative cardiovascular collapse secondary to latex allergy. J Urol 146: 571-574
130. Lie HR, Lagergren J, Rasmussen F et al. (1991) Bowel and bladder control of children with myelomeningocele: a Nordic study. Dev Med Child Neurol 33: 1053-1061
131. Kropp KA, Voeller KK (1981) Cryptorchidism in meningomyelocele. J Pediatr 99: 110-113
132. DGU (2001) Leitlinien der Deutschen Gesellschaft für Urologie: Diagnostik und Therapie von Libido- und Erektionsstörungen. AWMF-Leitlinien-Register Nr.043/031 Entwicklungsstufe: 1
133. Cass AS, Bloom BA, Luxenberg M (1986) Sexual function in adults with myelomeningocele. J Urol 136: 425-426
134. Woodhouse CR (2001) Prospects for fertility in patients born with genitourinary anomalies. J Urol 165: 2354-2360
135. Woodhouse CR (1998) Sexual function in boys born with exstrophy, myelomeningocele, and micropenis. Urology 52: 3-11
136. Palmer JS, Kaplan WE, Firlit CF (2000) Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol 164: 958-961
137. Löchner-Ernst D, Mandalka B (1997) Fertilitätsprogramm für querschnittgelähmte Männer - Übersicht und Ergebnisse. In: Stöhrer M, Madersbacher H, Palmtag H (Hrsg) Neurogene Sexualstörung. Springer, Berlin Heidelberg New York
138. Vylder A de, Driel MF van, Staal AL et al. (2004) Myelomeningocele and female sexuality: an issue? Eur Urol 46: 421-426
139. Koletzko B, Pietrzik K (2004) Gesundheitliche Bedeutung der Folsäurezufuhr. Dtsch Arztebl 101: 1670-1681
140. Beetz R, Bachmann H, Gatermann S et al. (2007) Urinary tract infections in infants and children - a consensus on diagnostic, therapy and prophylaxis. Urologe A 46(2): 112-123
141. Galloway A (1997) Prevention of urinary tract infection in patients with spinal cord injury - a microbiological review. Spinal Cord 35: 198-204
142. Biering-Sorensen F, Hoiby N, Nordenbo A et al. (1994) Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol 151: 105-108
143. Johnson HW, Anderson JD, Chambers GK et al. (1994) A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. Pediatrics 93: 752-755
144. Kuhlemeier KV, Stover SL, Lloyd LK (1985) Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 134: 514-517
145. Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 138: 336-340
146. Morton SC, Shekelle PG, Adams JL et al. (2002) Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 83: 129-138
147. Hauschild G, Schone D, Wasser S (1968) Follow-up therapy of urinary tract infections with ammonium chloride. Kinderarztl Prax 36: 441-446
148. Murphy FJ, Zelman S, Mau W (1965) Ascorbic acid as a urinary acidifying agent. 2. Its adjunctive role in chronic urinary infection. J Urol 94: 300-303
149. Nahata MC, Shrimp L, Lampman T, McLeod DC (1977) Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm 34: 1234-1237
150. Wall I, Tiselius HG (1990) Long-term acidification of urine in patients treated for infected renal stones. Urol Int 45: 336-341
151. Fünfstück R, Straube E, Schildbach O, Tietz U (1997) Reinfektionsprophylaxe durch L-Methionin bei Patienten mit einer rezidivierenden Harnwegsinfektion. Med Klinik 92: 574-581
152. Sobota AE (1984) Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infections. J Urol 131: 1013-1016
153. Jepson RG, Mihaljevic L, Craig J (2004) Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2: CD001321
154. Reid G, Hsiehl J, Potter PMed Klinik (2001) Cranberry juice consumption may reduce biofilms on uroepithelial cells: Pilot study in spinal cord injured patients. Spinal Cord 39: 26-30
155. Schlager TA, Anderson S, Trudell J, Hendley JO (1999) Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 135: 698-702
156. Lown B (Hrsg) (2004) Die verlorene Kunst des Heilens. Suhrkamp, Stuttgart
157. Erickson DV, Ray LD (2004) Children with chronic continence problems: The challenges for families. J Wound Ostomy Continence Nurs 31: 215-222
158. Sozialgesetzbuch (1998) Sozialgesetzbuch IX §§ 29 (Organisation) und 55 (Leistungen zur Teilhabe am Leben in der Gemeinschaft. Hilfen zum Erwerb praktischer Kenntnisse und Fähigkeiten). Sozialgesetzbuch
159. Zickler CF, Richardson V (2004) Achieving continence in children with neurogenic bowel and bladder. J Pediatr Health Care 18: 276-283
160. Buran CF, McDaniel AM, Brei TJ (2002) Needs assessment in a spina bifida program: A comparison of the perceptions by adolescents with spina bifida and their parents. Clin Nurse Spec 16: 256-262